The value of anti-CD30 CAR T cells in Hodgkin lymphoma

Lancet Haematol. 2024 May;11(5):e314-e316. doi: 10.1016/S2352-3026(24)00094-2. Epub 2024 Mar 28.

Author

Marianne Veyri¹

Affiliation

¹ Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Sante Publique (IPLESP), Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Pitié-Salpêtrière, Service d'Oncologie Médicale, Paris 75013, France. Electronic address: marianne.veyri@aphp.fr.

PMID: 38555922
DOI: 10.1016/S2352-3026(24)00094-2

No abstract available

MeSH terms

Hodgkin Disease* / immunology
Hodgkin Disease* / therapy
Humans
Immunotherapy, Adoptive* / methods
Ki-1 Antigen* / immunology
Ki-1 Antigen* / metabolism
Receptors, Chimeric Antigen / immunology
T-Lymphocytes / immunology

Substances

Ki-1 Antigen
Receptors, Chimeric Antigen